Auditory Prediction and Error Evaluation in the Speech of Individuals Who Stutter
Arizona State University · with University of Washington, National Institute on Deafness and Other Communication Disorders (NIDCD) · NCT06181149
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 3+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 300
- US sites recruiting
- 2
- Study start
- January 1, 2024
- Record last updated
- August 21, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Stuttering negatively impacts communication and reduces the overall quality of life and well-being of individuals who stutter. This study will provide a strong foundation for developing neural and behavioral interventions for stuttering. Participants will be asked to name pictures, read words/sentences silently or aloud, and listen to speech and nonspeech sounds while their speech, muscle, and brain signals are collected. Some participants may also receive brain stimulation while reading and speaking.
Being studied: Delaying speech initiation; Auditory errors and pre-speech auditory modulation; Contributions of the speech premotor cortex to pre-speech auditory modulation; Delaying auditory feedback
Conditions: Healthy Subjects; Stuttering, Developmental
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- being a monolingual, native speaker of American English
- absence of developmental, psychological, neurological, or communication disorders (other than developmental stuttering) as confirmed by a certified research SLP
- normal (age-appropriate) binaural pure-tone hearing threshold (0.5-4k Hz; ≤25 dB HL for younger than 70 years, and ≤35 dB HL for older than 70 years)
- not taking any medications that affect the central nervous system
- absence of safety contra-indication for tDCS, TMS and MRI (for adults)
- scoring at the 20th percentile or higher on standardized speech-language tests (for children)
Exclusion Criteria
-
Recruiting US locations
Arizona State University
Tempe, AZ 85287
Site contact: Ayoub Daliri · 480-727-8397 · ayoub.daliri@asu.edu
Univeristy of Washington
Seattle, WA 98105
Site contact: Ludo Max · 206-543-2674 · LudoMax@uw.edu
Study contacts (from the official record)
- Ayoub Daliri, PhD · 4807278397 · ayoub.daliri@asu.edu
Similar studies in Arizona
All healthy volunteers studies in Arizona →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Developing Biomarkers of Dietary Intake: Dose Dependent Measurement of Sugar Intake
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Location
- Phoenix, AZ
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234
AstraZeneca
- Location
- Chandler, AZ + 2 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingHealthy volunteersPhase 1
A Phase 1 Relative Bioavailability Study of a VX-581 Tablet Formulation
Vertex Pharmaceuticals Incorporated
- Location
- Tempe, AZ
- Eligibility basics
- Ages 18–55 · Men only
- RecruitingHealthy volunteersPhase 1
A Single and Multiple Ascending Dose Study of EPX-100 in Healthy Adult Participants
Epygenix
- Location
- Tempe, AZ
- Eligibility basics
- Ages 18–55